Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             40 results found
no title author magazine year volume issue page(s) type
1 A dose-range study assessing immunogenicity and safety of one dose of a new candidate meningococcal serogroups A, C, W-135, Y tetanus toxoid conjugate (MenACWY-TT) vaccine administered in the second year of life and in young children Knuf, M.
2010
28 3 p. 744-753
10 p.
article
2 A live bivalent influenza vaccine based on a H9N2 virus strain Wu, Rui
2010
28 3 p. 673-680
8 p.
article
3 Alphavirus replicon particle vaccines developed for use in humans induce high levels of antibodies to influenza virus hemagglutinin in swine: Proof of concept Erdman, M.M.
2010
28 3 p. 594-596
3 p.
article
4 A novel assay for influenza virus quantification using surface plasmon resonance Estmer Nilsson, C.
2010
28 3 p. 759-766
8 p.
article
5 A novel human parainfluenza virus type 1 (HPIV1) with separated P and C genes is useful for generating C gene mutants for evaluation as live-attenuated virus vaccine candidates Bartlett, Emmalene J.
2010
28 3 p. 767-779
13 p.
article
6 A practical influenza neutralization assay to simultaneously quantify hemagglutinin and neuraminidase-inhibiting antibody responses Hassantoufighi, Arash
2010
28 3 p. 790-797
8 p.
article
7 Attitudes toward and intention to receive the human papilloma virus (HPV) vaccination and intention to use condoms among female Korean college students Kang, Hee Sun
2010
28 3 p. 811-816
6 p.
article
8 Comparative varicella vaccine effectiveness during outbreaks in day-care centres Spackova, M.
2010
28 3 p. 686-691
6 p.
article
9 Comparison of single, homologous prime-boost and heterologous prime-boost immunization strategies against H5N1 influenza virus in a mouse challenge model Sabarth, Nicolas
2010
28 3 p. 650-656
7 p.
article
10 Cross-neutralisation of Australian brown snake, taipan and death adder venoms by monovalent antibodies Isbister, Geoffrey K.
2010
28 3 p. 798-802
5 p.
article
11 Dose ranging of adjuvant and antigen in a cell culture H5N1 influenza vaccine: Safety and immunogenicity of a phase 1/2 clinical trial Keitel, Wendy
2010
28 3 p. 840-848
9 p.
article
12 Economic impact of the introduction of an acellular pertussis vaccine in Canada: A 6-year analysis Iskedjian, Michael
2010
28 3 p. 714-723
10 p.
article
13 Editorial Board 2010
28 3 p. CO2-
1 p.
article
14 Evaluation of a commercial bovine viral diarrhea virus vaccine in nonpregnant female alpacas (Vicugna pacos) Byers, Stacey R.
2010
28 3 p. 591-593
3 p.
article
15 Evaluation of the adjuvant properties of Astragalus membranaceus and Scutellaria baicalensis GEORGI in the immune protection induced by UV-attenuated Toxoplasma gondii in mouse models Yang, Xiaoyan
2010
28 3 p. 737-743
7 p.
article
16 Expanding immunization coverage in rural India: A review of evidence for the role of community health workers Patel, Amit R.
2010
28 3 p. 604-613
10 p.
article
17 George Martin Baer 1936–2009 Wilde, Henry
2010
28 3 p. 868-
1 p.
article
18 Hepatitis A and E: Update on prevention and epidemiology FitzSimons, David
2010
28 3 p. 583-588
6 p.
article
19 Hepatitis B vaccines: WHO position paper—Recommendations 2010
28 3 p. 589-590
2 p.
article
20 Immunity after natural exposure to enteric canine coronavirus does not provide complete protection against infection with the new pantropic CB/05 strain Decaro, Nicola
2010
28 3 p. 724-729
6 p.
article
21 Immunogenicity and safety of IXIARO® (IC51) in a Phase II study in healthy Indian children between 1 and 3 years of age Kaltenböck, A.
2010
28 3 p. 834-839
6 p.
article
22 Immunogenicity and tolerability of a quadrivalent meningococcal glycoconjugate vaccine in children 2–10 years of age Black, S.
2010
28 3 p. 657-663
7 p.
article
23 Immunotherapy with the saponin enriched-Leishmune® vaccine versus immunochemotherapy in dogs with natural canine visceral leishmaniasis Borja-Cabrera, G.P.
2010
28 3 p. 597-603
7 p.
article
24 Improved vaccination against Newcastle disease by an in ovo recombinant HVT-ND combined with an adjuvanted live vaccine at day-old Rauw, Fabienne
2010
28 3 p. 823-833
11 p.
article
25 Incompletely matched influenza vaccine still provides protection in frail elderly Dean, Anna S.
2010
28 3 p. 864-867
4 p.
article
26 Innate immune defense in visceral leishmaniasis: Cytokine mediated protective role by allogeneic effector cell Manna, Partha Pratim
2010
28 3 p. 803-810
8 p.
article
27 Long-term protection provided by hepatitis B vaccine and need for booster dose: A meta-analysis Poorolajal, Jalal
2010
28 3 p. 623-631
9 p.
article
28 MCV vaccination in the presence of vaccine-associated Guillain–Barré Syndrome risk: A decision analysis approach Cho, Bo-Hyun
2010
28 3 p. 817-822
6 p.
article
29 Persistence of antibodies and immune memory to hepatitis B vaccine 20 years after infant vaccination in Thailand Poovorawan, Yong
2010
28 3 p. 730-736
7 p.
article
30 Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses Guy, Bruno
2010
28 3 p. 632-649
18 p.
article
31 Priming with AS03A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: An open non-randomised extension of a double-blind randomised primary study Leroux-Roels, Isabel
2010
28 3 p. 849-857
9 p.
article
32 Recombinant A27 protein synergizes with modified vaccinia Ankara in conferring protection against a lethal vaccinia virus challenge He, Yong
2010
28 3 p. 699-706
8 p.
article
33 Reduction in hospitalizations for diarrhea and rotavirus infections in New York state following introduction of rotavirus vaccine Chang, Hwa-Gan H.
2010
28 3 p. 754-758
5 p.
article
34 Subcutaneous inoculation of a whole virus particle vaccine prepared from a non-pathogenic virus library induces protective immunity against H7N7 highly pathogenic avian influenza virus in cynomolgus macaques Itoh, Yasushi
2010
28 3 p. 780-789
10 p.
article
35 Successful seroresponses to measles and rubella following aerosolized Triviraten vaccine, but poor response to aerosolized mumps (Rubini) component: Comparisons with injected MMR Diaz-Ortega, Jose Luis
2010
28 3 p. 692-698
7 p.
article
36 Systemic, nasal and oral live vaccines against Pseudomonas aeruginosa: A clinical trial of immunogenicity in lower airways of human volunteers Bumann, Dirk
2010
28 3 p. 707-713
7 p.
article
37 The role of complement in innate and adaptive immunity to pneumococcal colonization and sepsis in a murine model Bogaert, D.
2010
28 3 p. 681-685
5 p.
article
38 The role of Toll-like receptors and C-type lectins for vaccination against Candida albicans Ferwerda, Gerben
2010
28 3 p. 614-622
9 p.
article
39 Universal influenza DNA vaccine encoding conserved CD4+ T cell epitopes protects against lethal viral challenge in HLA-DR transgenic mice Alexander, Jeff
2010
28 3 p. 664-672
9 p.
article
40 Vaccine wastage in Bangladesh Guichard, Stephane
2010
28 3 p. 858-863
6 p.
article
                             40 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands